CARDIZEM CD Drug Patent Profile

✉ Email this page to a colleague

When do Cardizem Cd patents expire, and what generic alternatives are available?

Cardizem Cd is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in CARDIZEM CD is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cardizem Cd

A generic version of CARDIZEM CD was approved as diltiazem hydrochloride by TEVA on May 31^st, 1995.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CARDIZEM CD?
What are the global sales for CARDIZEM CD?
What is Average Wholesale Price for CARDIZEM CD?

Summary for CARDIZEM CD

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	131
Clinical Trials:	10
Patent Applications:	2,870
Drug Prices:	Drug price information for CARDIZEM CD
What excipients (inactive ingredients) are in CARDIZEM CD?	CARDIZEM CD excipients list
DailyMed Link:	CARDIZEM CD at DailyMed

Drug patent expirations by year for CARDIZEM CD

Recent Clinical Trials for CARDIZEM CD

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assiut University	Early Phase 1
CAMC Health System	Phase 4
University of South Florida	N/A

See all CARDIZEM CD clinical trials

Pharmacology for CARDIZEM CD

Drug Class	Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists Cytochrome P450 3A4 Inhibitors

US Patents and Regulatory Information for CARDIZEM CD

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-001	Aug 10, 1992	AB3	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-004	Dec 27, 1991	AB3	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-002	Dec 27, 1991	AB3	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CARDIZEM CD

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-003	Dec 27, 1991	⤷ Sign Up	⤷ Sign Up
Bausch	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-003	Dec 27, 1991	⤷ Sign Up	⤷ Sign Up
Bausch	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-002	Dec 27, 1991	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CARDIZEM CD

See the table below for patents covering CARDIZEM CD around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Germany	3856555		⤷ Sign Up
European Patent Office	0514814	Formulation à base de diltiazem (Diltiazem formulation)	⤷ Sign Up
Taiwan	265267		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for CARDIZEM CD

Recent Clinical Trials for CARDIZEM CD

Pharmacology for CARDIZEM CD

Make Better Decisions: Try a trial or see plans & pricing